Learn / TSHA
NASDAQ: TSHA
Taysha Gene Therapies (TSHA) stock, explained like you're 5
Taysha Gene Therapies trades on the Nasdaq under the ticker TSHA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
- Ticker
- TSHA
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 1.5 billion dollars
Is Taysha Gene Therapies a small, medium or large cap company?
No. Taysha Gene Therapies is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Taysha Gene Therapies makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves TSHA stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- TSHA Oct 2026 11.000 call (TSHA261016C00011000) Interactive Stock Chart (Yahoo! Finance Canada)
- Taysha Gene Therapies stock hits 52 week low at 3.69 USD (Investing.com)
- Taysha Gene Therapies (TSHA) Stock Retreats As Cash Burn Deepens (Simply Wall Street)
- Taysha Gene Therapies (TSHA) Stock May Be Above Fair Value On Book Value (Yahoo Finance)
- Taysha Gene Therapies (TSHA) Stock Looks Undervalued After Sharp Three Year Recovery (Yahoo Finance)
Follow TSHA in your daily brief
Each trading day at 5 PM ET we post what happened to Taysha Gene Therapies and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow TSHA
Questions about Taysha Gene Therapies stock
What does Taysha Gene Therapies do?
Taysha Gene Therapies trades on the Nasdaq under the ticker TSHA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
What is the ticker symbol for Taysha Gene Therapies?
Taysha Gene Therapies trades under the ticker TSHA on the Nasdaq.
What is Taysha Gene Therapies's market cap?
Taysha Gene Therapies is a small cap stock with a market cap of about 1.5 billion dollars.
How does Taysha Gene Therapies make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves TSHA stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow TSHA stock every day?
Add TSHA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.